Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#2 clBTC clBTC +12.15%
#3 OpenEden OpenEden +11.48%
#4 BasedHype BasedHype +11.14%
#5 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.73%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.41%
#7 Mantle Staked Ether Mantle Staked Ether +8.34%
#8 Mantle Restaked ETH Mantle Restaked ETH +8.01%
#9 MarsCoin MarsCoin +6.65%
#10 EfficientFrontier EfficientFrontier +4.93%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Rangering i aksjer #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Aksjekurs
$0.00162013
Sist synkronisert: 2025-01-03
Markedsverdi
$156.25K
Endring (1 dag)
0.36%
Endring (1 år)
0.00%
Land
SE
Handel Cyxone AB (publ) (CYXO)

Kategori

Healthcare
P/S-forhold for Cyxone AB (publ) (CYXO)
P/S-forhold per August 2026 TTM: 1.31
Ifølge Cyxone AB (publ) sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 1.31. Ved slutten av 2022 hadde selskapet et P/S-forhold på 6.98.
P/S-historikk for Cyxone AB (publ) fra 2015 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 1.31 -30.24%
2023 1.88 -72.98%
2022 6.98 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 6.23K -93.33%
2018 93.45K 0.00%
2017 0.00 -100.00%
2016 4.88K 24.54%
2015 3.92K 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 653.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 685.65%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 279.69%
BE